This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Haxhihamza K, Arsova S, Bajraktarov S, Kalpak G, Stefanovski B, Novotni A, Milutinovic M. Patient Satisfaction with Use of Telemedicine in University Clinic of Psychiatry: Skopje, North Macedonia During COVID-19 Pandemic. Telemed, J E Health. 27(4):464-467, 2021Search in Google Scholar
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21, 335–337Search in Google Scholar
Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25, 2020Search in Google Scholar
Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1:565–567, 2020Search in Google Scholar
Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis: a national population based modelling study. Lancet Oncol. 21:1023–1034, 2020.Search in Google Scholar
Sud, A., Torr, B., Jones, M. E., Broggi, J., Scott, S., Loveday, C., Garrett, A., Gronthoud, F., Nicol, D. L., Jhanji, S., Boyce, S. A., Williams, A., Riboli, E., Muller, D. C., Kipps, E., Larkin, J., Navani, N., Swanton, C., Lyratzopoulos, G., McFerran, E., Lawler, M., Houlston, R. & Turnbull, C. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 21:1034–1044, 2020Search in Google Scholar
UK Lung Cancer Coalition (UKLCC). COVID-19 Matters: A Review of the Impact of COVID-19 on the Lung Cancer Pathway and Opportunities for Innovation Emerging from the Health System Response to the Pandemic COVID-19 (UKLCC, 2020)Search in Google Scholar
de Joode K, Dumoulin DW, Engelen V, et al. Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective. Eur J Cancer 136:132-9, 2020Search in Google Scholar
Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-CoV-2: a multi-center study during the COVID-19 outbreak. Cancer Discov 10:783–91, 2020Search in Google Scholar
Helsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G. et al. Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID‐19. Eur. J. Cancer Care 29, e13290, 2020Search in Google Scholar
Khan, N., Jones, D., Grice, A., Alderson, S., Bradley, S., Carder, P. et al. A brave new world: the new normal for general practice after the COVID-19 pandemic. BJGP Open 4, bjgpopen20X101103, 2020Search in Google Scholar
British Thoracic Society. COVID-19: information for the respiratory community. https://www.brit-thoracic.org.uk/about-us/covid-19-information-for-therespiratory-community/ (2020).Search in Google Scholar
Horn, L., Whisenant, J. G., Torri, V., Huang, L.-C., Trama, A., Paz-Ares, L. G. et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): impact of type of cancer therapy and COVID therapy on survival. Am. Soc. Clin. Oncol. 38, LBA111, 2020Search in Google Scholar
Luo, J., Rizvi, H., Preeshagul, I. R., Egger, J. V., Hoyos, D., Bandlamudi, C. et al. COVID-19 in patients with lung cancer. Ann. Oncol. 31, 1386–1396, 2020Search in Google Scholar
Antonoff, M., Backhus, L., Boffa, D. J., Broderick, S. R., Brown, L. M. et al. COVID-19 guidance for triage of operations for thoracic malignancies: a consensus statement from thoracic surgery outcomes research network. J. Thorac. Cardiovasc. Surg. 160, 601–605, 2020Search in Google Scholar
Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: an ESTRO-ASTRO consensus statement. Radiother Oncol 146:223–9, 2020Search in Google Scholar
Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 12:269–73, 2020Search in Google Scholar
Calabrò L, Peters S, Soria J-C, et al. Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 8:542–4, 2020Search in Google Scholar
Bakhribah H, Zeitouni M, Daghistani RA, et al. Implications of COVID-19 pandemic on lung cancer management: a multidisciplinary perspective. Crit Rev Oncol Hematol 156:103120, 2020Search in Google Scholar
Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–34, 2020Search in Google Scholar
Calles, A., Aparicio, M. I., Alva, M., Bringas, M., Gutierrez, N., Soto, J. et al. Outcomes of COVID-19 in patients with lung cancer treated in a tertiary hospital in Madrid. Front. Oncol. 10, 1777, 2020Search in Google Scholar
Thomas Round, Veline L’Esperance, Joanne Bayly et al. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. British Journal of Cancer 125:629–640, 2021.Search in Google Scholar